A Trump-Touted Drug for Autism Is Now in Demand, but Doctors See a Dilemma

JN ACCESS RANKING

• 

  Japan’s Hopes for Seafood Exports Shot Down in China Spat

• 

  Essential Services Shortage to Hit Japan’s GDP By Up to ¥76 Tril. By 2040

• 

  Japan to Charge Foreigners More for Residence Permits, Looking to Align with Western Countries

• 

  Japan Exports Rise in October as Slump in U.S. Sales Eases

• 

  Niigata Gov. to OK Restart of N-Plant; Kashiwazaki-Kariwa May Be Tepco’s 1st Restarted Plant Since 2011